TY - JOUR
T1 - Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers
AU - Soula, Mariluz
AU - Weber, Ross A.
AU - Zilka, Omkar
AU - Alwaseem, Hanan
AU - La, Konnor
AU - Yen, Frederick
AU - Molina, Henrik
AU - Garcia-Bermudez, Javier
AU - Pratt, Derek A.
AU - Birsoy, Kıvanç
N1 - Funding Information:
We thank all members of the Birsoy Lab for helpful suggestions and also members of the Rockefeller University Genomics Resource Center, Proteomics Resource Center and the Flow Cytometry Resource Center for their assistance. We also thank K. Johnsson (Max Planck Institute of Medical Research) and C. Woolf (Boston Children’s Hospital) for their generous gift of QM385. Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health (T32GM066699; M.S.) and by the NIH Director’s New Innovator Award (DP2 CA228042–01; K.B.), Pershing Square Sohn Foundation (K.B.), AACR NextGen Grant (K.B.), the Natural Sciences and Engineering Research Council of Canada (D.A.P.) and Canada Foundation for Innovation (D.A.P.). J.G.-B. is a Special Fellow of the Leukemia & Lymphoma Society. K.B. is a Searle Scholar, Pew-Stewart Scholar and Sidney Kimmel Scholar.
Publisher Copyright:
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc.
PY - 2020/12
Y1 - 2020/12
N2 - Cancer cells rewire their metabolism and rely on endogenous antioxidants to mitigate lethal oxidative damage to lipids. However, the metabolic processes that modulate the response to lipid peroxidation are poorly defined. Using genetic screens, we compared metabolic genes essential for proliferation upon inhibition of cystine uptake or glutathione peroxidase-4 (GPX4). Interestingly, very few genes were commonly required under both conditions, suggesting that cystine limitation and GPX4 inhibition may impair proliferation via distinct mechanisms. Our screens also identify tetrahydrobiopterin (BH4) biosynthesis as an essential metabolic pathway upon GPX4 inhibition. Mechanistically, BH4 is a potent radical-trapping antioxidant that protects lipid membranes from autoxidation, alone and in synergy with vitamin E. Dihydrofolate reductase catalyzes the regeneration of BH4, and its inhibition by methotrexate synergizes with GPX4 inhibition. Altogether, our work identifies the mechanism by which BH4 acts as an endogenous antioxidant and provides a compendium of metabolic modifiers of lipid peroxidation. [Figure not available: see fulltext.]
AB - Cancer cells rewire their metabolism and rely on endogenous antioxidants to mitigate lethal oxidative damage to lipids. However, the metabolic processes that modulate the response to lipid peroxidation are poorly defined. Using genetic screens, we compared metabolic genes essential for proliferation upon inhibition of cystine uptake or glutathione peroxidase-4 (GPX4). Interestingly, very few genes were commonly required under both conditions, suggesting that cystine limitation and GPX4 inhibition may impair proliferation via distinct mechanisms. Our screens also identify tetrahydrobiopterin (BH4) biosynthesis as an essential metabolic pathway upon GPX4 inhibition. Mechanistically, BH4 is a potent radical-trapping antioxidant that protects lipid membranes from autoxidation, alone and in synergy with vitamin E. Dihydrofolate reductase catalyzes the regeneration of BH4, and its inhibition by methotrexate synergizes with GPX4 inhibition. Altogether, our work identifies the mechanism by which BH4 acts as an endogenous antioxidant and provides a compendium of metabolic modifiers of lipid peroxidation. [Figure not available: see fulltext.]
UR - http://www.scopus.com/inward/record.url?scp=85089251565&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089251565&partnerID=8YFLogxK
U2 - 10.1038/s41589-020-0613-y
DO - 10.1038/s41589-020-0613-y
M3 - Article
C2 - 32778843
AN - SCOPUS:85089251565
SN - 1552-4450
VL - 16
SP - 1351
EP - 1360
JO - Nature Chemical Biology
JF - Nature Chemical Biology
IS - 12
ER -